FR2518879B3 - - Google Patents

Info

Publication number
FR2518879B3
FR2518879B3 FR8124481A FR8124481A FR2518879B3 FR 2518879 B3 FR2518879 B3 FR 2518879B3 FR 8124481 A FR8124481 A FR 8124481A FR 8124481 A FR8124481 A FR 8124481A FR 2518879 B3 FR2518879 B3 FR 2518879B3
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8124481A
Other languages
French (fr)
Other versions
FR2518879A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BESINS JEAN
Original Assignee
BESINS JEAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BESINS JEAN filed Critical BESINS JEAN
Priority to FR8124481A priority Critical patent/FR2518879A1/en
Publication of FR2518879A1 publication Critical patent/FR2518879A1/en
Application granted granted Critical
Publication of FR2518879B3 publication Critical patent/FR2518879B3/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8124481A 1981-12-30 1981-12-30 Topical oestradiol compsns. - for treatment of disorders associated with menopause Granted FR2518879A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8124481A FR2518879A1 (en) 1981-12-30 1981-12-30 Topical oestradiol compsns. - for treatment of disorders associated with menopause

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8124481A FR2518879A1 (en) 1981-12-30 1981-12-30 Topical oestradiol compsns. - for treatment of disorders associated with menopause

Publications (2)

Publication Number Publication Date
FR2518879A1 FR2518879A1 (en) 1983-07-01
FR2518879B3 true FR2518879B3 (en) 1985-02-08

Family

ID=9265514

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8124481A Granted FR2518879A1 (en) 1981-12-30 1981-12-30 Topical oestradiol compsns. - for treatment of disorders associated with menopause

Country Status (1)

Country Link
FR (1) FR2518879A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1780610B (en) * 2003-04-28 2010-06-09 舍林股份公司 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
US8466136B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE275957T1 (en) * 1993-01-19 2004-10-15 Endorech Inc THERAPEUTIC USES AND ADMINISTRATION SYSTEMS OF DEHYDROEPIANDROSTERONE
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
IT1283102B1 (en) * 1996-06-06 1998-04-07 Permatec Nv THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ESTROGENIC OR PROGESTINIC ACTIVE SUBSTANCE OR OF THEIR MIXTURES
FR2772270B1 (en) * 1997-12-15 2002-06-07 Besins Iscovesco Lab USE OF AN ESTROGEN FOR THE TREATMENT OF POSTNATAL DEPRESSION
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
FR2851470B1 (en) 2003-02-20 2007-11-16 Besins Int Belgique PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCTIVE DELIVERY
US7879357B2 (en) 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US9132089B2 (en) 2000-08-30 2015-09-15 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
CN1780610B (en) * 2003-04-28 2010-06-09 舍林股份公司 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
US8466136B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8466137B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8466138B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8486925B2 (en) 2005-10-12 2013-07-16 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8729057B2 (en) 2005-10-12 2014-05-20 Unimed Pharmaeuticals, LLC Testosterone gel and method of use
US8741881B2 (en) 2005-10-12 2014-06-03 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8754070B2 (en) 2005-10-12 2014-06-17 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8759329B2 (en) 2005-10-12 2014-06-24 Unimed Pharmaceuticals, Llc Testosterone gel and method of use

Also Published As

Publication number Publication date
FR2518879A1 (en) 1983-07-01

Similar Documents

Publication Publication Date Title
FR2500460B1 (en)
DE3247247C2 (en)
DE3205046C2 (en)
DE3235288C2 (en)
DE3220606C2 (en)
DE3229774C2 (en)
DE3129744C2 (en)
FR2498963B1 (en)
FR2499505B1 (en)
DE3137191C2 (en)
DE3128412C2 (en)
FR2499473B1 (en)
DE3211612C2 (en)
FR2500434B1 (en)
DE3127560C2 (en)
DE3150249C2 (en)
DE3203831C2 (en)
DE3127379C2 (en)
DE3207808C2 (en)
DE3131394C2 (en)
DE3204101C2 (en)
DE3128565C2 (en)
CH655541B (en)
DE3223441C2 (en)
DE3221625C2 (en)